Crossmark

Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring

Crossref DOI link: https://doi.org/10.1186/s12920-020-0671-8

Published Online: 2020-03-04

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Crowgey, Erin L.

Mahajan, Nitin

Wong, Wing Hing

Gopalakrishnapillai, Anilkumar

Barwe, Sonali P.

Kolb, E. Anders

Druley, Todd E. http://orcid.org/0000-0002-3245-7561
Funding

Funding for this research was provided by:

National Cancer Institute (CA211711-01)

Siteman Cancer Center Research Fund (13-FY16-01)

Hyundai Hope On Wheels (2015Q3-3)

Children's Discovery Institute (MC-II-2015-461)

Leukemia Research Foundation of Delaware (2018)
License Information

Text and Data Mining valid from 2020-03-04

Version of Record valid from 2020-03-04
More Information

Article History

Received: 26 April 2019

Accepted: 24 January 2020

First Online: 4 March 2020

Consent for publication

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below